Mitchell P. Kopin 13D and 13G filings for Processa Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-23 06:03 am Purchase | 2025-06-17 | 13G | Processa Pharmaceuticals, Inc. PCSA | Mitchell P. Kopin | 3,018,238 9.990% | 3,018,238 (New Position) | Filing |